Page last updated: 2024-08-17

cycloheximide and toremifene

cycloheximide has been researched along with toremifene in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL	1
Kuramoto, M; Ogawa, M; Yamashita, J	1
Alitalo, K; Härkönen, PL; Joukov, V; Karkkainen, MJ; Ruohola, JK; Valve, EM	1

Reviews

1 review(s) available for cycloheximide and toremifene

Article	Year
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective. Medicinal research reviews, 2021, Volume: 41, Issue:1 Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization	2021

Other Studies

2 other study(ies) available for cycloheximide and toremifene

Article	Year
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells. Cancer, 1995, Mar-15, Volume: 75, Issue:6 Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured	1995
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Molecular and cellular endocrinology, 1999, Mar-25, Volume: 149, Issue:1-2 Topics: Animals; Breast Neoplasms; Cycloheximide; Cyproterone Acetate; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Female; Humans; Lymphokines; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Steroids; Tamoxifen; Testosterone; Toremifene; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1999

Article

Year

Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.

Cancer, 1995, Mar-15, Volume: 75, Issue:6

Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured

1995

Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.

Molecular and cellular endocrinology, 1999, Mar-25, Volume: 149, Issue:1-2

Topics: Animals; Breast Neoplasms; Cycloheximide; Cyproterone Acetate; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Female; Humans; Lymphokines; Mammary Neoplasms, Experimental; Mice; Neoplasms, Hormone-Dependent; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Steroids; Tamoxifen; Testosterone; Toremifene; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1999